Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-21 6:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 582,284 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:40 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14.04 | $140,423 | 1,181,152 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-19 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 600,281 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 6:51 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 610,281 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Exercise |
2025-03-21 6:30 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 582,284 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-21 6:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 582,284 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
152,300 | $0 | 152,300 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 1,181,152 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 1,181,152 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 600,281 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 600,281 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 6:51 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 610,281 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 6:51 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 610,281 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:47 pm |
N/A 2034-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-10 6:00 pm |
N/A 2032-05-24 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
614,588 | $0 | 614,588 (Direct) |
View |